Pharmaceutical Company Speeds Up New Drug Application Process
A top priority for a large pharmaceutical company was to produce drugs to prevent and treat COVID-19. The process of identifying the best candidates, starting and completing clinical trials, and gaining regulatory approval typically required 18-36 months. Industry and government must collaborate and advancements in AI for drug discovery and fast-tracking of required regulatory documentation are needed to help with the vaccine.
The pharmaceutical company used intelligent RPA to aggregate information from multiple sources to fast track the completion of regulatory documents for new COVID-19 drugs. This included automating communications and monitoring responses from regulatory agencies.
reduction in NDA process
of quality checks for
regulatory documents automated